Former Louisiana Attorney General Warns Organon Investors of Class Action Deadlines

On July 4, 2025, Kahn Swick & Foti, LLC (KSF), along with its partner Charles C. Foti, Jr., a former Louisiana Attorney General, provided an urgent reminder for investors who faced losses exceeding $100,000 in Organon & Co. (NYSE: OGN). Investors holding shares during the class period between October 31, 2024, and April 30, 2025, have until July 22, 2025, to submit their lead plaintiff applications in a federal class action suit against the company.

Organon is currently under scrutiny for allegedly failing to disclose material information regarding its finances, thereby violating federal securities laws. This legal action is pending in the United States District Court for the District of New Jersey and aims to hold Organon accountable for its actions. Investors are encouraged by KSF to seek fair recourse for their financial losses as the situation develops.

A critical incident occurred on March 10, 2025, when Organon reported its financial results for the first quarter. During this announcement, management revealed a substantial cut in the company’s dividend payout, slashing it from $0.28 to $0.02. This news was particularly alarming to shareholders, as it starkly contradicted earlier assurances that maintaining the dividend was a top priority for the company. Consequently, the value of Organon shares plummeted over 27% within a day, falling from a closing price of $12.93 on April 30 to just $9.45 by May 1, 2025.

This drastic decline in share price further fueled investor concern, as many relied on the company's prior commitments while making investment decisions. Furthermore, failed dividends can significantly impact an investor's perceived value and overall return on investment. Therefore, the decision to engage in legal action through a class action suit aims to recover losses for the affected investors.

Kahn Swick & Foti offers guidance and assistance for individuals seeking to understand their legal rights and the potential impact of their investments in Organon. Interested investors can connect with KSF Managing Partner Lewis Kahn at 1-877-515-1850 or via email at info@ksfcounsel.com. Additional information is available on KSF's website, where individuals can learn more about the ongoing case and how to file for lead plaintiff status before the July deadline.

Founded by Charles C. Foti, Jr., Kahn Swick & Foti, LLC has built a commendable reputation as one of the country's leading boutique securities litigation law firms. Recent standings show KSF as one of the top 10 national firms, recognized by SCAS for their substantial settlements achieved for clients. They advocate for both institutional and retail investors seeking justice against corporate malfeasance.

Organon remains at the center of this critical class action as it grapples with this legal challenge. The results of the lawsuit could have significant implications for investors, particularly those reliant on dividends as a source of income.

As time is of the essence, affected parties should act swiftly. The outcome could lead to sizable recoveries for investors wronged by Organon’s disclosure practices and subsequent financial results.

To summarize, if you are among those who purchased Organon shares within the specified class period and have suffered losses, it is vital to consider your next steps promptly. The opportunity to pursue accountability through this class action is available, yet the clock is ticking until the indicated deadline.

Topics Financial Services & Investing)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.